Brimonidine tartrate is an alpha-adrenergic agonist used to lower eye pressure by reducing fluid production.
Brimonidine tartrate is a medication that belongs to the class of α-adrenergic agonists. It works mainly to lower pressure inside the eye, which helps protect the optic nerve from damage. You will find this active ingredient in several eye-drop products, most notably the combination product Combigan.
In Hong Kong, brimonidine tartrate is available primarily as part of Combigan eye-drops, which combine brimonidine with timolol. Combigan is supplied in sterile ophthalmic solutions packaged in small bottles for single-eye use. While the combination product is the most common, generic versions of brimonidine tartrate alone are also authorised for sale in Hong Kong, typically in 0.15 % or 0.2 % concentrations. All of these products are prescription-only and must be dispensed by a pharmacy under the oversight of the Department of Health’s Pharmacy and Poisons Board.
These uses are approved by Hong Kong health authorities, and the medication is prescribed for adults and older children who can safely handle eye-drop therapy.
When applied as eye-drops, brimonidine tartrate narrows tiny blood vessels in the front part of the eye. This narrowing reduces the amount of fluid that enters the eye, while also helping fluid drain away more efficiently. The result is a quicker drop in intra-ocular pressure, often noticeable within an hour of use. Because the effect is local to the eye, systemic side effects are usually minimal.
These reactions are generally short-lived and tend to improve as the eye adjusts to the medication.
For detailed interaction lists, refer to the specific product’s information sheet.
Store brimonidine eye-drops in a cool, dry place away from direct sunlight and keep the bottle tightly closed. Do not freeze the solution. Most prescriptions are intended for short-term or ongoing control of eye pressure; the exact duration depends on the individual’s condition and the specific product used. Always follow the instructions printed on the medication label and the guidance given with your prescription. For detailed usage, dosing, and administration, refer to your specific medication’s information.
This article offers general educational information about brimonidine tartrate as an active substance used in various medicines. Its purpose is to help patients better understand the ingredient and the conditions it is used to treat. It is not a substitute for professional medical advice or for the specific instructions provided with individual products. Medicines containing brimonidine tartrate may differ in formulation, strength, and directions for use. Always consult the labeling of your particular medication and follow your healthcare provider’s guidance for complete information on proper use, dosage, and safety.